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Abstract
In today’s stressful world, psychopathy (especially anxiety) is receiving increased importance. Most of the drugs used to treat this
disease have several side effects. Medicinal plants derived from natural products have fewer side effects and can be used in the
treatment of this disease. The aim of this study was to evaluate the effect of the hydroalcoholic extract of Rosmarinus officinalis L.
on anxiety in mice. In this experimental study, 50 male mice were randomly divided into 5 groups. To evaluate anxiety, the
Elevated Plus Maze test was performed. The control group received normal saline, the positive control group received diazepam
(1 mg/kg) as intraperitoneal injection, and the experimental groups received doses of 100, 200, and 400 mg/kg body weight of
rosemary extract. The data were analyzed using SPSS 15 and ANOVA statistical tests. The results show that rosemary extract
dose-dependently increases the mice spending time and the entries number of mice in plus maze open arms (indicating less stress).
This effect at a dose of 400 mg/kg was similar to diazepam, which, in comparison to the control group, was statistically significant (P
< .01), while the evaluation of locomotor activity in treated groups, compared with the control groups, showed no significant
difference (P > .05). On the other hand, the rosemary extract, similar to the standard drug diazepam, showed an anti-anxiety
effect. This effect is probably due to the presence of flavonoids in this plant and their antioxidant property.
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In today’s stressful world, psychopathy (especially anxiety) has
received increased importance because of its high prevalence.1
Anxiety is a feeling of fear and discomfort caused by no spe-
cific reason, which undermines peoples’ function and is the
main and most common symptom of psychopathy. During the
history of psychology, this disorder has always been considered
due to adverse consequences; therefore, in this field many
studies have been carried out and huge financial resources and
human resources have been allocated to treat anxiety.2 Accord-
ing to World Health Organization, estimation of the prevalence
of this disorder is increasing in developing countries. The
World Health Organization estimates anxiety as one of the top
mental disorders, with a population of 500 million suffering
worldwide.3 According to recent studies of the Anxiety and
Depression Association of America, of every 10 US adults 7
claim that they have experienced either anxiety or stress at least
on a daily basis and at an intermediate level.4 According to
surveys in Iran, anxiety, with a prevalence of 2.3%, was at the
top of mental disorders, and on this basis 20.8% of those sur-
veyed suffer from symptoms of anxiety.3 Due to the different
side effects and harmful effects of some industrial medicines,
many patients prefer alternative and complementary medicines
for treatment. A study in a population more than 2000 people
demonstrated that more than half of those who suffer from
anxiety attacks use medicinal herbs or other complementary
therapies to treat their disorders. Although all herbal medicines
are not safe, most herbal products that are used in
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psychotherapy are relatively safe and have fewer side effects
than chemical drugs, such as antidepressants.5
Among the effective medicinal plants used in the treat-
ment of mental disorders, rosemary can be noted. Rosemary
(Rosmarinus officinalis L.) belongs to the Lamiaceae or
Labiatae family and is a perennial plant with a shrub form
and evergreen branches that rise to a height of 2 meters by
mast and are occasionally lying on the ground as branches;
they are green and have a fragrance. The leaves of this plant
and the main branches are collected in the spring and sum-
mer for pharmaceutical purposes. This plant is native to
Mediterranean and South European countries, and is also
cultivated in Iran.6
Volatile oil is the main component derived from the leaves
of this plant, and its most important compounds include trici-
cline, 1,8-cineole, camphor, camphene, and bornyl acetate,
which vary depending on the geographical conditions and the
altitude of cultivation. The hydromethanolic plant extract con-
tains flavonoids such as luteolin, phenolic acid, diterpenes,
triterpenes, tannins, and resins.7
Clinical studies indicate that rosemary has multiple pharma-
cological properties and helps in reducing high blood glucose,8
increases secretion of bile,9 and has antimicrobial, anti-
inflammatory, antifungal,10 smooth muscle relaxant, antioxi-
dant, anti–skin allergy,11 and antimutagenic properties.12 The
plant is valuable in the pharmaceutical and medical industry
due to its antimicrobial, antimutagenic, and chemical preven-
tion agent properties. Rosemary’s essential oil is used for fla-
voring food, is used in the cosmetic industry, and is also used as
disinfectants and pesticides.6 This plant’s essence increases
blood circulation in organs, has antirheumatic effects, and
reduces neuralgia.13 Rosemary’s analgesic effects are due to
opioid receptors. In ancient medicine, the plant has been used
for treating anxiety.11,14
Most of the drugs used to treat anxiety cause several adverse
reactions such as anticholinergic effects, arrhythmias, and
hypotension.15 The selective serotonin reuptake inhibitor anti-
depressant family is a new drug class used in therapy and is
used as a first-line treatment, for example, citalopram at 20 to
60 mg per day doses, and but has side effects such as nausea,
vomiting, sexual dysfunction, agitation, and insomnia.16 On the
other hand, benzodiazepines as an adjunct drug is used in the
treatment of anxiety and insomnia in depressed patients. This
drug should be used with caution because of the risks of drug
dependency.17 Although many drugs are used to treat mental
illness, physicians believe that these drugs’ therapeutic
responses are not enough, and patients are unable to tolerate
their side effects; however, herbal medicines have fewer side
effects and can be used alone or as a supplement in the treat-
ment of this disorder.18 The effectiveness of the different med-
icinal plants in treating depression has been demonstrated.
Studies have shown that plants of the Lamiaceae family are
effective in treating mental disorders and anxiety.19 With
regard to the effects of rosemary in the treatment of mental
disorders using traditional medicine, we decided to investigate
rosemary’s potential effects on anxiety.
Materials and Methods
Animals
To perform this experimental study, 50 mice (weight range of 25-35 g)
with an average age of 8 weeks were obtained from the Pasteur Insti-
tute (Tehran, Iran). The animals did not have any infectious disease
and all were healthy. The animals were kept in plastic cages in a room
at a temperature of about 22C to 24C, suitable environmental con-
ditions, and 12 hours of darkness/light; also, they were given food and
water indefinitely. During the study, all the other mice were kept in the
same conditions and were unchanged. The study followed ethics and
animal care manual protocols published by the National Institutes of
Health.
Extraction
The rosemary plant was obtained from an area surrounding Sanandaj
and was then identified and confirmed by a member of Shahrekord
Plant Research Center as Rosmarinus officinalis L species. The plant
sheets were washed in flowing water and then were dried for 2 days
at room temperature. In addition, the Maceration method was used
for extraction. For this purpose, the leaves and twigs of the rosemary
plant after separation from other parts were ground in an electric
mill. Then 500 gr of the powder in combination with 70% alcohol
(2 L) was soaked for 72 hours in an environment protected from
light. After filtering the resulting liquid by a rotary device (distilla-
tion in a vacuum) twice, it was incubated at 40C to evaporate the
solvent and then the extract was dried after distillation.20 All stages
of extraction were done in sterilized containers. Due to the required
concentration the extract was diluted with normal saline (Daru
Pakhsh Company, Tehran, Iran) and doses of 100, 200, and 400
mg/kg body weidht were prepared.
Experiments
The positive control group was administered diazepam at a dose of
1 mg/kg. Also, for the experimental groups, doses of 100, 200, and
400 mg/kg body weight of rosemary hydroalcoholic extract was admi-
nistered, while the control group received normal saline. All animals
received 0.2 mL of drug intraperitoneally. This test was performed
according to the method introduced by Walf and Frye.21 The Elevated
Plus Maze device (Stoelting Co, Wood Dale, IL) is an unconditional
model used to produce and measure anxiety, determine the drug’s
anxiety and antianxiety effects, and does not require any practical
training and learning. This device is currently the most reliable means
of production and evaluation of anxiety in animal models. The device
consists of 2 open and 2 closed arms against each other to form a ‘‘þ’’
(40 cm long, 10 cm wide). The 2 arms have no walls (open arms), but
the closed arms are surrounded by 40 cm walls. At the center is a 10
10 cm box. The device is placed 50 cm above the ground, so that a
40 Watt bulb to a height of 1 meter is mounted on top of it. After
45 minutes of injection, each rat in the middle of the device is placed
on its head into the open arms, and testing is done for 5 minutes. When
the animals enter the open arms by seeing height, they get scared and
quickly go to the closed arm to be protected. The best criterion to
measure anxiety is by the presence and number of open arm entries. It
should be noted that the presence span and the number of entries into
the open arm has an inverse relationship to the anxiety level. That is,
the more the duration of presence or the entries in the arm the less the
anxiety. The arrival of every 4 feet of the animal was considered as
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inclusion and exclusion criteria to the different parts of the system.22
Within 5 minutes, the time spent in the open and closed arms and the
number of entries to both arms were recorded separately, and the time
spent in open arms (%OAT; %Open Arm Time), the percentage of
entries into open arms (%OAE; %Open Arm Entries), and the Loco-
motor Activity were calculated as standard factors of the anxiety
measure.
%Open Arm Time ð%OATÞ: Time spent in open arms
divided by the time spent in both arms  100
%Open Arm Entries ð%OAEÞ: Number of entries into the
open arms divided by the number of entries in both arms
 100
Locomotor Activity : Total entry into the open and closed
arms
Each animal was tested only once in order to not let the animal
learn. The device numbers of the entries in both the opened and the
closed arm are locomotor activities. Whenever there are more entries
into the arms, they are signs for increased Locomotor Activity. This
test is designed to differentiate between the effect of antianxiety drugs
and the effect of activity reactions.23 Following each test, all parts of
the system that had been in contact with animals were cleaned with
cotton and alcohol and then dried.
Statistical Analysis
Data were analyzed by using SPSS15 software, one-way ANOVA was
followed by least significant difference tests for post hoc analysis.
Differences with P < .05 were considered significant. Data were
expressed as mean + SEM.
Results
Comparison between the means and standard deviations of
measured variables in different groups is presented in
Figures 1 to 5. The results showed that the hydroalcoholic
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Figure 1. Comparison of different doses of hydroalcoholic extracts
of rosemary and diazepam to control group on spent time in the open
arm of the Elevated Plus Maze in mice.
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Figure 2. Comparison of different doses of hydroalcoholic extracts
of rosemary and diazepam to control group on spent time in the
closed arm of the Elevated Plus Maze in mice.
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Figure 3. Comparison of rosemary hydroalcoholic extract and dia-
zepam at different doses to control group on percentage of entries
into the Elevated Plus Maze open arms in mice.
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Figure 4. Comparison of rosemary hydroalcoholic extract and dia-
zepam at different doses to control group on percentage of entries
into the Elevated Plus Maze closed arms in mice.
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extract of rosemary increases the time mice spent in plus maze
open arms (indicating less stress). This effect was dose-
dependent, and at higher doses the results were more effective.
The effect of the extract on survival time of the mice in the
open arms at a dose of 400 mg/kg was similar to the effect of
diazepam at a dose of 1 mg/kg, which in comparison to the
control group was significant (P < .01; Figure 1). Furthermore,
under treatment, the time mice spent in the closed arm dose-
dependently decreased, and at a dose of 400 mg/kg was similar
to the effect of diazepam (P < .01; Figure 2). In addition, in this
test, the spent time in the open arms and the number of entries
was calculated so that the results were in line with OAT, and
the treated groups in comparison to the control group entered
more number of times into the open arm (P < .05; Figure 3).
Also, the number of entries of experimental groups mice into
the closed arm decreased dose dependently (P < .05; Figure 4).
Locomotor activity in the treated groups was compared with
the control group, and the positive control group showed no
significant difference (P > .05; Figure 5).
Discussion
The aim of this study was to evaluate the effect of the hydro-
alcoholic extract of rosemary on anxiety in mice. The results
showed that rosemary in a dose-dependent manner increases
the entry and the time spent by the mice in the Plus Maze open
arm (indicating less stress). In addition, it does not have a
significant effect on locomotor activity. The effect of this herb
in high doses was similar to that of diazepam. The rosemary
plant contains luteolin, phenolic acid, diterpenes, triterpenes,
tannins, and resins. These compounds may increase the plant’s
effects on different areas of the central nervous system. Diaze-
pam, as a benzodiazepine drug, has proven sedative effects on
the central nervous system; also, it is considered as an anxio-
lytic drug. Diazepam through interaction with brain GABA
receptors, particularly in the reticular formation of the mid-
brain, can cause sedative and anxiolytic effects.24 Studies have
shown a wide role of neurochemical systems in the phenom-
enon of anxiety. But the GABAergic system and the GABA A
receptor are the most involved systems in anxiety. After ligand-
receptor binding, the chlore channel opens, and it causes inhi-
bition and hyperpolarization of neurons.
Rosemary is rich in flavonoids; flavonoids serve as ligand
for central nervous system receptors and, thus, might act like
benzodiazepines. This hypothesis was confirmed by behavioral
studies that were done on anxiety behavior and sedation and
seizures in animal models.25 Flavonoids, especially apigenin
(one of the active constituents of rosemary), are able to cross
the blood-brain barrier, and as a positive and allosteric regula-
tor it enhances GABA effects on GABA receptors; unlike dia-
zepines, they do not cause dependence after an anti-anxiety
effect.26
Luteolin is another flavonoid in rosemary that also has seda-
tion and anti-anxiety effects by binding to GABA receptors.
Another effective combination is carnosic acid, and its antide-
pressant effect was proved by Kumar et al.27 Rosemary’s seda-
tive effects are possibly due to its antioxidant property.28 Free
radicals such as superoxide, hydrogen peroxide, hydroxyl, and
lipid peroxidation radicals cause damage to nerve tissues, and
as a result causes neurodegenerative diseases such as epilepsy,
schizophrenia, Parkinson’s disease, Alzheimer’s disease, and
exacerbate mental illness, anxiety, and stress.29
Parisa et al showed that rosemary has powerful antioxidant
effects.30 Probably this plant with its antioxidant properties
protects the brain and other tissues from damage from free
radicals. Probably rosemary through oxidative stress reduction
and cell protection against apoptosis causes serotonergic neu-
ron protection and anxiety reduction. Rosemary with its anti-
inflammatory properties prevents inflammation-causing agents
such as tumor necrosis factors-a, denaturation of proteins, and
decreases dopaminergic and serotonergic neuron damage.
Dopamine is able to stimulate ACTH secretion by the pitui-
tary, and this neurotransmitter plays a role in reducing anxiety.
Therefore, rosemary through MAO might probably create pro-
tective effects on neurons and cause anxiety reduction. In the
study by Hosseinzadeh et al, it was observed that the hydro-
alcoholic extract of rosemary is similar to diazepam, and it
reduces symptoms of morphine deprivation syndrome in
mice.31 In that study, it was found that some fractions of the
plant reduces emotional states and anxiety, and also by reduc-
ing the action of GABA receptors the leaning is reduced.
Conclusions
The present study showed that the hydroalcoholic extract of
rosemary, especially in high doses, has anxiolytic effects. This
effect is probably due to the presence of flavonoids and their
antioxidant properties in removing free radicals. Also, the pres-
ence of compounds such as apigenin, carnosic acid, and luteo-
lin are involved in the anti-anxiety effects of rosemary. It is
recommended that subsequent studies look more closely at the
rosemary plant’s mechanism of action, and also its active
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Figure 5. Comparison of rosemary hydroalcoholic extract and dia-
zepam at different doses to control group on the Elevated Plus Maze
locomotor activity in mice.
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ingredients, in the hope that in the future the efficacy of this
plant could be used in clinical studies.
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